Annovis Announces New Publication in a Peer-Reviewed Journal

MALVERN, Pa., May 21, 2024 -- Annovis Bio, Inc. , a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, announced the publication of a new article...

Related Keywords

Malvern , Pennsylvania , United States , Posiphen Pharmacokinetics , Annovis Bio , Maria Maccecchini , Annovis Bio Inc , Securities Exchange , Company Annual Report On Form , Twitter , Linkedin , Special Issue , Amyloid Protein , Comparative Analysis , Different Species , Similar Absorption , Securities Act , Securities Exchange Act , Annual Report , Quarterly Reports ,